Ekaterina Koltsova

Dr. Ekaterina Koltsova

orcid

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 June 2018 in PLOS ONE
Verified
Journal Article
Open access
PDF file
ABAnna N. Balandina
Anna N. Balandina
ISIlya I Serebriyskiy
Ilya I Serebriyskiy
APAlexander V Poletaev
Alexander V Poletaev
DPDmitrii Polokhov
Dmitrii Polokhov
MGMarina A Gracheva
Marina A Gracheva
FAFazoil I Ataullakhanov
Fazoil I Ataullakhanov
Heparin therapy and prophylaxis may be accompanied by bleeding and thrombotic complications due to individual responses to treatment. Dosage control based on standard laboratory assays poorly reflects the effect of the therapy. The aim of our work was to compare the heparin sensitivity of new thrombodynamics (TD) assay with sensitivity of other standard and global coagulation tests available to date. A total of 296 patients with high risk of venous thromboembolism (deep vein thrombosis (DVT), early postoperative period, hemoblastosis) were enrolled in the study. We used a case-crossover design to evaluate the sensitivity of new thrombodynamics assay (TD) to the hemostatic state before and after unfractionated heparin (UFH) and low-molecular-weight heparin (LMWH) therapy/prophylaxis and to compare it with the activated partial thromboplastin time (APTT), anti-Xa activity test, thrombin generation test (TGT) and thromboelastography (TEG). A receiver operating characteristic (ROC) curve analysis was used to evaluate changes before and after heparin prophylaxis and therapy. Blood was sampled before heparin injection, at the time of maximal blood heparin concentration and before the next injection. Hypercoagulation before the start of heparin treatment was detected by TD, TGT and TEG but not by APTT. The area under the ROC curve (AUC) was maximal for TD and anti-Xa, intermediate for TGT and TEG and minimal for APTT. These results indicate that TD has a high sensitivity to the effects of UFH and LMWH after both prophylactic and therapeutic regimes and may be used for heparin monitoring.

21 September 2016 in Seminars in Thrombosis and Hemostasis
Verified
Journal Article
Closed access
PDF file
EKEkaterina Koltsova
Ekaterina Koltsova
ABAnna N. Balandina
Anna N. Balandina
ISIlya I. Serebriyskiy
Ilya I. Serebriyskiy
TVTatiana A. Vuimo
Tatiana A. Vuimo
MPMikhail A. Panteleev
Mikhail A. Panteleev
FAFazoil I. Ataullakhanov
Fazoil I. Ataullakhanov
Pregnancy is associated with a significant procoagulant shift in the hemostatic system balance as well as other metabolic changes. Pregnancy can thereby provoke manifestation of otherwise dormant disorders of hemostasis (e.g., thrombophilia), or even cause new, pregnancy-specific disorders (e.g., HELLP syndrome). Application and interpretation of laboratory assays of hemostasis in pregnancy is particularly challenging, because normal physiological ranges are no longer applicable, and because the most dangerous and complex changes are not detected by classic routine coagulation/platelet assays. New global assays of coagulation and of platelet-dependent hemostasis appear to be promising in this respect, but are still far from clinical practice and rarely appear in current patient management guidelines. These global assays require a high level of research to identify their relationship to clinically significant outcomes. Here, we review the state-of-the-art knowledge of the molecular changes in the hemostatic system in normal pregnancy and during pregnancy-related complications (preeclampsia, thrombotic microangiopathies, antiphospholipid syndrome, etc.). We also discuss the sensitivity of various classic and innovative assays to these pregnancy-associated changes, and describe current and potential future applications of these assays in meeting specific clinical needs.

18 September 2018 in Pediatric Research
Verified
Journal Article
Closed access
PDF file
EKEkaterina Koltsova
Ekaterina Koltsova
EBEkaterina N. Balashova
Ekaterina N. Balashova
AIAnastasiya A. Ignatova
Anastasiya A. Ignatova
APAlexander V. Poletaev
Alexander V. Poletaev
DPDmitrii Polokhov
Dmitrii Polokhov
ABAnna N. Balandina
Anna N. Balandina

15 December 2021 in PLOS ONE
Verified
Journal Article
Open access
PDF file
EKEkaterina Koltsova
Ekaterina Koltsova
MSMaria Sorokina
Maria Sorokina
APAlexandra S. Pisaryuk
Alexandra S. Pisaryuk
NPNikita M. Povalyaev
Nikita M. Povalyaev
AIAnastasia A. Ignatova
Anastasia A. Ignatova
ABAnna N. Balandina
Anna N. Balandina
Background: Coagulation system is heavily involved into the process of infective endocarditis (IE) vegetation formation and can facilitate further embolization. In this study we aimed to assess the coagulation and platelet state in IE implementing a wide range of standard and global laboratory assays. We also aim to determine whether prothrombotic genetic polymorphisms play any role in embolization and mortality in IE patients. Methods: 37 patients with IE were enrolled into the study. Coagulation was assessed using standard coagulation assays (activated partial thromboplastin time (APTT), prothrombin, fibrinogen, D-dimer concentrations) and integral assays (thromboelastography (TEG) and thrombodynamics (TD)). Platelet functional activity was estimated by flow cytometry. Single nuclear polymorphisms of coagulation system genes were studied. Results: Fibrinogen concentration and fibrinogen-dependent parameters of TEG and TD were increased in patients indicating systemic inflammation. In majority of patients clot growth rate in thrombodynamics was significantly shifted towards hypercoagulation in consistency with D-dimers elevation. However, in some patients prothrombin, thromboelastography and thrombodynamics were shifted towards hypocoagulation. Resting platelets were characterized by glycoprotein IIb-IIIa activation and degranulation. In patients with fatal IE, we observed a significant decrease in fibrinogen and thrombodynamics. In patients with embolism, we observed a significant decrease in the TEG R parameter. No association of embolism or mortality with genetic polymorphisms was found in our cohort. Conclusions: Our findings suggest that coagulation in patients with infective endocarditis is characterized by general hypercoagulability and platelet pre-activation. Some patients, however, have hypocoagulant coagulation profile, which presumably can indicate progressing of hypercoagulation into consumption coagulopathy.

23 May 2019 in PLOS ONE
Verified
Journal Article
Open access
PDF file
ABAnna N. Balandina
Anna N. Balandina
EKEkaterina Koltsova
Ekaterina Koltsova
TTT. A. Teterina
T. A. Teterina
AYA. G. Yakovenko
A. G. Yakovenko
ESE. U. Simonenko
E. U. Simonenko
FAF. I. Ataullakhanov
F. I. Ataullakhanov
The shift towards hypercoagulation during in vitro fertilization (IVF) can lead to the impairment of embryo implantation and placental blood circulation, which is believed to be a factor in an unsuccessful IVF cycle. To assess coagulation in women with infertility before the start of an IVF cycle and during treatment to reveal the association between coagulation imbalance and IVF outcome. We conducted a prospective cohort observational study including 125 participants who underwent fresh IVF cycles. Blood samples were collected at five time points: before IVF, one week after the start of controlled ovarian stimulation (COS), on the day of follicular puncture, on the day of embryo transfer (ET) and one week after ET. Coagulation tests (clotting times: activated partial thromboplastin time (APTT) and prothrombin; fibrinogen and D-dimer concentrations; thrombodynamics) were performed. Women with an elevated clot growth velocity (>32.3 μm/min, detected by thrombodynamics) before IVF demonstrated a higher risk of negative IVF outcomes (adjusted RR = 1.38; 95% CI 1.28–1.49; P<0.001). During the procedure, we observed increases in prothrombin, fibrinogen and D-dimer concentrations, a slight shortening of APTT and a hypercoagulation shift in the thrombodynamics parameters. The hemostasis assay values during COS and after ET had no associations with IVF outcomes. Hypercoagulation in the thrombodynamics before the start of IVF treatment was associated with negative IVF outcomes. After the start of COS, all tests demonstrated a hypercoagulation trend, but the hypercoagulation did not influence IVF outcome. This research is potentially beneficial for the application of thrombodynamics assay for monitoring hemostasis in infertile women prior to an IVF procedure with the goal of selecting a group requiring hemostasis correction to increase the chances of pregnancy.

1 October 2018 in Thrombosis Research
Verified
Journal Article
Closed access
APA.V. Poletaev
A.V. Poletaev
EKEkaterina Koltsova
Ekaterina Koltsova
АIА.A. Ignatova
А.A. Ignatova
AKA.D. Kuprash
A.D. Kuprash
PGP.G. Gitelson
P.G. Gitelson
МPМ.A. Panteleev
М.A. Panteleev